By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Australian genetic test development firm Genetic Technologies said today it has completed a financing round that raised A$11.7 million (US$12.7 million).

The funds were raised through a private placement of 60 million new shares at A$.195 per share to institutional and private investors in Australia and the US. The offering was oversubscribed and 12 new institutional investors participated in the placement, Genetic Technologies said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: issues in reproducibility, circulating DNA predicts breast cancer relapse, and more.

Because of an autoimmune disorder, a man has been shedding live polioviruses for 28 years, according to an analysis appearing in PLOS Pathogens.

Being in a long-term collaboration can increase researchers' citation rates by 17 percent, a recent analysis says.

By analyzing tweets, Canadian researchers examine the public's view of gene patenting.